NanOlogy
  • Home
  • About
  • Technology
    • Overview
    • Purcision Technology
  • Development
    • Investigational Drugs
    • Pipeline
    • Clinical Trials
    • Partnering Opportunities
  • News & Publications
  • Contact Us
    • Partnering Opportunities
    • Physicians and Patients
Post placeholder image
January 3, 2018 in NanOlogy in the News

PharmaVOICE: Next-Generation Nanomedicines

NanOlogy 0 Like Post Comments Off on PharmaVOICE: Next-Generation Nanomedicines
Read More
Post placeholder image
January 3, 2018 in NanOlogy Press Release, Soria

NanOlogy to Present Update on Cancer Treatment Clinical Program at Biotech Showcase in San Francisco

NanOlogy 0 Like Post Comments Off on NanOlogy to Present Update on Cancer Treatment Clinical Program at Biotech Showcase in San Francisco

  Download PDF NanOlogy to Present Update on Cancer Treatment Clinical Program at Biotech Showcase in San Francisco Company has six Phase 2 trials underway and a composition patent jus ...

Read More
NanOlogy

NanOlogy investigational drugs have not yet been proven to be safe and effective in accordance with the requirements of the U.S. FDA and are not approved by FDA or any other jurisdiction for commercial distribution. NanOlogy, NanoPac, and NanoDoce are trademarks of NanOlogy, LLC.    Purcision is a trademark to CritiTech, Inc.  © NanOlogy LLC      Legal